References
- Gharib H: Current evaluation of thyroid nodules. Trends Endocrinol Metab. 1994;5:365-369 https://doi.org/10.1016/1043-2760(94)90103-1
- Mazzaferri EL: Management of a solitary thyroid nodule. N Engl J Med. 1993;328:553-558 https://doi.org/10.1056/NEJM199302253280807
- Chow SM, Law SCK, Chan JKC, et al: Papillary microcarcinoma of the thyroid-prognostic significance of lymph node metastasis and multifocality. Cancer. 2003;98:31-40 https://doi.org/10.1002/cncr.11442
- Piersanti M, Ezzat S, Asa SL: Controversies in papillary microcarcinoma of the thyroid. Endocrine Pathol. 2003;l4:183-192 https://doi.org/10.1007/s12022-003-0011-5
- Li Volsi VA: Surgical pathology of the thyroid. Philadelphia. Saunders, 1990
- Rosai J, Carcagiu ML, DeLellis RA: Tumors of thyroid gland. In: Atlas of tumor pathology, Fascicle 5, 3rd Series. Washington, DC. Armed Forces Institute of Pathology, 1992
- Rosai J: Ackerman's surgical pathology. St Louis. Mosby Co., 2004
- Aratake Y, Umeki K, Kiyoyama K, et al: Diagnostic utility of galectin-3 and CD26/DPPIV as preoperative diagnostic markers for thyroid nodules. Diagn Cytopathol. 2002;26:366-372 https://doi.org/10.1002/dc.10111
- Casey MB, Lohse CM, Lloyd RV: Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3, and HBME-1. Endocr Pathol. 2003;14:55-60 https://doi.org/10.1385/EP:14:1:55
- Garcia S, Vassko V, Henry JF, De Micco C: Comparison of thyroid peroxidase expression with cellular proliferation in thyroid follicular tumors. Thyroid. 1998;8:745-759 https://doi.org/10.1089/thy.1998.8.745
- Zeiger MA, Smallridge RC, Clark DP, et al: Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasm. Surgery. 1999;126:1195-1198 https://doi.org/10.1067/msy.2099.101374
- Park MI, Kang DY: Usefulness of galectin-3, cytokertin 19, p53, and Ki-67 for the differential diagnosis of thyroid tumors. Korean J Pathol. 2006;40:86-92
- Cvejic D, Savin S, Petrovic I, et al: Galecin-3 expression in papillary microcarcinoma of the thyroid. Histopathology. 2005;47:209-214 https://doi.org/10.1111/j.1365-2559.2005.02199.x
- Barondes SH, Cooper DVW, Gitt MA, et al: Galectins: structure and function of a large family of animal lectins. J Biol Chem. 1994;69:20807-20810
- Hapke M, Dehner LP: The optically clear nucleus. A reliable sign of papillary carcinoma of the thyroid? Am J Surg Pathol. 1979;3:31-38 https://doi.org/10.1097/00000478-197902000-00004
- Xu XC, El Naggar AK, Lotan R: Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. Am J Pathol. 1995;147:815-822
- Giannini R, Faviana P, Cavinato T, et al: Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens. Thyroid. 2003;13:765-770 https://doi.org/10.1089/105072503768499662
- Beesley MF, McLaren KM: Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules. Histopathology. 2002;41:236-243 https://doi.org/10.1046/j.1365-2559.2002.01442.x
- Orlandi F, Saggiorato E. Pivano G, et al: Galectin-3 is a presurgical marker of human thyroid carcinoma. Cancer Res. 1998;58:3013-3020
- Nikiforova MN, Lynch RA, Biddinger PW, et al: RAS point mutations and PAX8-PPAR rearrangement in thyroid tumors. Evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab. 2003;88:2318-2326 https://doi.org/10.1210/jc.2002-021907
- Prasad ML, Huang Y, Pellegata NS, et al: Hashimoto's thyroiditis with papillary thyroid carcinoma-like nuclear alterations express molecular markers. Histopathology. 2004;45:39-46 https://doi.org/10.1111/j.1365-2559.2004.01876.x
- van Hoeven KH, Kovatich AJ, Miettinen M: Immunocytochemical evaluation of HBME-1, CA 19-9, and CD-5 (Leu-M1) in fine-needle aspirates of thyroid nodules. Diagn Cytopathol. 1998;18:93-97
- Sack MJ, Astengo-Osuna C, Lin BT, et al: HBME-1 immunostaining in thyroid fine-needle aspirations: a useful marker in the diagnosis of carcinoma. Mod Pathol. 1997;10:668-674